SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001019687-14-000490
Filing Date
2014-02-12
Accepted
2014-02-12 19:25:31
Documents
1
Period of Report
2014-02-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT jafco_f4.html 4  
1 OWNERSHIP DOCUMENT jafco_f4.xml 4 18166
  Complete submission text file 0001019687-14-000490.txt   19875
Mailing Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 400 CAMBRIDGE MA 02142 617-871-9911
Eleven Biotherapeutics, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 252025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address OTEMACHI FIRST SQUARE, WEST TOWER 11F 1-5-1 OTEMACHI CHIYODA-KU, TOKYO 100-0004 M0 100-0004
Business Address OTEMACHI FIRST SQUARE, WEST TOWER 11F 1-5-1 OTEMACHI CHIYODA-KU, TOKYO 100-0004 M0 100-0004 81-3-5223-7008
JAFCO Super V3 Investment Limited Partnership (Reporting) CIK: 0001590442 (see all company filings)

State of Incorp.: M0 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 14602297